Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: A systematic review.

Aunchalee JaroenlapnopparatManeerat ChayanupatkulPisit Tangkijvanich

Published in: Journal of gastroenterology and hepatology (2021)

Combining HBcrAg with HBV RNA or HBsAg improved the discriminating abilities in the prediction of off-treatment relapse of each test. Patients with double-negative HBcrAg and HBV RNA at EOT had low risks of relapse and could be considered for NA discontinuation.

Keyphrases

hepatitis b virus
end stage renal disease
chronic kidney disease
ejection fraction
free survival
sars cov
peritoneal dialysis
prognostic factors
combination therapy
risk assessment
patient reported